Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Esperion Therapeutics Inc
NASDAQ:ESPR

Watchlist Manager
Esperion Therapeutics Inc Logo
Esperion Therapeutics Inc
NASDAQ:ESPR
Watchlist
Price: 3.475 USD -1%
Market Cap: $830.7m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

Assets
+
3Y
+16%
5Y
+45%
10Y
+19%
Liabilities
+
3Y
+34%
5Y
+237%
10Y
+8 136%
Equity
+
3Y
-53%
5Y
-
10Y
-

Balance Sheet Decomposition
Esperion Therapeutics Inc

Balance Sheet
Esperion Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-1998 Dec-1999 Dec-2000 Dec-2001 Dec-2002 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
13
6
70
70
41
2
7
57
85
77
38
35
37
166
305
209
125
82
145
Cash Equivalents
13
6
70
70
41
2
7
57
85
77
38
35
37
166
305
209
125
82
145
Short-Term Investments
0
0
0
0
4
0
0
4
21
135
173
166
99
35
0
50
42
0
0
Total Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23
34
48
80
Accounts Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23
34
48
80
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16
34
35
66
94
Other Current Assets
0
0
1
1
0
0
1
1
1
2
2
4
7
11
25
12
11
5
19
Total Current Assets
13
6
71
71
45
2
7
61
107
214
214
204
143
212
346
329
247
201
338
PP&E Net
1
2
3
3
3
0
0
0
1
1
1
0
1
3
7
3
1
5
6
PP&E Gross
1
2
3
3
3
0
0
0
1
1
1
0
1
3
7
3
1
5
6
Accumulated Depreciation
0
1
1
2
4
1
1
1
0
0
1
1
1
1
2
2
3
2
2
Intangible Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Goodwill
0
0
4
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
0
0
0
0
0
0
18
36
80
31
73
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
50
0
0
0
Other Assets
0
0
4
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
13
N/A
8
-40%
78
+874%
78
+1%
51
-34%
2
-96%
7
+232%
78
+973%
143
+83%
296
+106%
245
-17%
278
+13%
144
-48%
214
+49%
353
+65%
382
+8%
248
-35%
206
-17%
344
+67%
Liabilities
Accounts Payable
0
1
4
3
2
1
1
2
2
1
5
20
45
29
52
18
23
32
52
Accrued Liabilities
0
1
3
3
2
1
1
2
3
3
9
12
19
30
35
39
41
64
84
Short-Term Debt
0
0
0
0
0
0
15
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
1
1
1
1
0
0
0
1
2
2
1
0
0
0
0
0
35
102
Other Current Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
7
7
17
28
25
9
Total Current Liabilities
0
3
7
6
5
1
17
4
6
6
16
33
64
66
94
73
92
156
246
Long-Term Debt
0
2
3
6
8
7
8
0
4
3
1
0
0
0
179
258
260
502
484
Other Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
128
176
247
220
3
3
Total Liabilities
0
N/A
5
+2 500%
10
+96%
12
+16%
13
+8%
8
-35%
25
+201%
4
-83%
10
+131%
8
-14%
17
+100%
33
+99%
64
+94%
195
+202%
449
+131%
579
+29%
572
-1%
661
+16%
733
+11%
Equity
Common Stock
0
0
0
0
0
24
24
0
0
0
0
0
0
0
0
0
0
0
0
Retained Earnings
2
13
40
65
94
30
42
68
104
154
229
396
598
695
839
1 106
1 340
1 549
1 601
Additional Paid In Capital
15
17
111
133
133
0
1
142
238
442
458
642
678
715
798
964
1 071
1 149
1 267
Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
55
55
55
55
55
Other Equity
0
1
3
1
1
0
0
0
0
1
0
1
0
0
0
0
0
0
0
Total Equity
13
N/A
3
-79%
68
+2 318%
67
-2%
39
-42%
6
N/A
17
-185%
74
N/A
134
+80%
287
+115%
229
-20%
245
+7%
79
-68%
20
-75%
96
N/A
197
-105%
324
-64%
455
-41%
389
+15%
Total Liabilities & Equity
13
N/A
8
-40%
78
+874%
78
+1%
51
-34%
2
-96%
7
+232%
78
+973%
143
+83%
296
+106%
245
-17%
278
+13%
144
-48%
214
+49%
353
+65%
382
+8%
248
-35%
206
-17%
344
+67%
Shares Outstanding
Common Shares Outstanding
2
2
26
29
29
0
0
15
20
23
23
26
27
28
26
61
75
118
196
Preferred Shares Outstanding
11
11
0
0
0
24
24
0
0
0
0
0
0
0
0
0
0
0
0

See Also

Summary
ESPR intrinsic value, competitors valuation, and company profile.
DCF Valuation
ESPR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ESPR stock valuation using valuation multiples.
Wall Street Estimates
ESPR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ESPR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 314,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.